People in the general population with biopsy-confirmed celiac disease, pooled worldwide

0.8%

percent of people in the general population, worldwide (meta-analysis of 87 articles, 394,274 participants)

“Global seroprevalence was 1.5% (95% CI, 1.3%-1.8%; I2 = 97.1%) and biopsy-confirmed prevalence of CeD was 0.8% (95% CI, 0.6%-1.0%; I2 = 94.9%).”

Gastroenterology 2026, Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-Analysis, 2026-08-18

Kind of source

Peer-reviewed study

Read on

2026-11-07

Daily check

Quote found at the source on 2026-11-07

What to know

Biopsy-confirmed prevalence (95% CI 0.6% to 1.0%), the measure of people with the disease itself. The same study's 1.5% seroprevalence counts antibody-positive people and is the measure Singh 2018's 1.4% (singh-2018-celiac-prevalence) used.

About

Celiac disease